PRS Pharmaceuticals Private Limited
About PRS Pharmaceuticals Private Limited
Data last updated:
PRS Pharmaceuticals Private Limited is a private limited company based in Salem, Tamil Nadu, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 04 October 2004 and has been in existence for over 22 years.
The company is registered with the Registrar of Companies (ROC), Coimbatore, under CIN U24231TZ2004PTC011374. Its GSTIN is 33AAECP0186F1ZP (Tamil Nadu).
The company has an authorised share capital of ₹12 Lakh and a paid-up capital of ₹12 Lakh. It is led by directors including Rajamanickam (Managing Director) and Rajendran.
Its last annual general meeting (AGM) was held on 30 November 2021, and its latest financial statements are for the year ended 31 March 2021. The registered office is at No. 9 Udayar Thottam Mallamoopampatty, Salem, Tamil Nadu, India – 636302.
As per the financials filed for FY 2019, the company reported a revenue of ₹7.16 Cr, a growth of 40% compared to the previous year. For the same year it recorded a net profit of ₹2.9 Lakh (net margin 0.4%) and EBITDA of ₹7.66 Lakh (EBITDA margin 1.1%). Revenue has grown at a compounded annual rate (CAGR) of 62% over three years and 36% over five years.
The company has about 21 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹77.47 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
PRS Pharmaceuticals Private Limited's registered office is in Salem, Tamil Nadu. Its e-mail address is in the company report.
- Email
- Registered AddressNo. 9 Udayar Thottam Mallamoopampatty, Salem, Tamil Nadu, India – 636302
- IndustryPharma, Drug Formulation & Development
To see the full contact details of PRS Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of PRS Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of PRS Pharmaceuticals Private Limited, buy the company report.
Financials of PRS Pharmaceuticals Private Limited
FY 2021 filings availablePRS Pharmaceuticals Private Limited reported revenue of ₹7.16 Cr (up 40% YoY) for FY 2019.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 36% over five years, including 40% growth in the latest year. EBITDA rose 3% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹7.16 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹7.66 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2.9 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.1% | ||||
| Net Profit Margin | 0.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of PRS Pharmaceuticals Private Limited, buy the company report.
Board of directors of PRS Pharmaceuticals Private Limited
PRS Pharmaceuticals has 3 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rajendran | Director | 21 Apr 2015 | 11 Years 6 Months | Current |
| Sekar Raji | Director | 04 Oct 2004 | 22 Years 1 Months | Current |
| Rajamanickam | Managing Director | 04 Oct 2004 | 22 Years 1 Months | Current |
Peer comparison
PRS Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Kaisha Lifesciences Private Limited | ₹7.16 Cr (FY 2025) | 2052.0% | Mumbai, Maharashtra, India | |||
| Bileshwar Pharmaceuticals Private Limited | ₹7.16 Cr (FY 2025) | -34.0% | Jhagadia, Gujarat, India | |||
| PRS Pharmaceuticals Private Limitedthis company | ₹7.16 Cr (FY 2019) | ₹2.9 Lakh | 0.4% | 40.0% | 21 | Salem, Tamil Nadu, India |
| Chereso Life Sciences Private Limited | ₹7.13 Cr (FY 2024) | -22.0% | Derrabassi, Punjab, India | |||
| Delexcel Pharma Private Limited | ₹7.13 Cr (FY 2022) | -33.0% | Medak, Telangana, India |
To see the full peer comparison of PRS Pharmaceuticals Private Limited, buy the company report.
Shareholding
The shareholding of PRS Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2019, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of PRS Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 30 Jan 2016 | 10628140 | Indian Overseas Bank | ₹50 Lakh | Open | |
| 09 Oct 2014 | 10533176 | Indian Overseas Bank | ₹27.47 Lakh | Open |
To see the full charge records of PRS Pharmaceuticals Private Limited, buy the company report.
Total charge records: 2 View all charges
Legal cases
No court or tribunal cases involving PRS Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for PRS Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
PRS Pharmaceuticals Private Limited has a workforce of 21 employees on its EPFO records as of Apr 05, 2024, across 1 active EPFO establishment.
GST
PRS Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 33AAECP0186F1ZP | Tamil Nadu | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of PRS Pharmaceuticals Private Limited, buy the company report.
Recent activity
PRS Pharmaceuticals Private Limited has 6 board changes on record since 2004: 3 appointments and 3 cessations. The latest: Perumal Ramar ceased to be Director on 02 Feb 2021.
1 earlier event is in the company report.
Frequently asked questions
PRS Pharmaceuticals is an active private limited company based in Salem, Tamil Nadu, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 04 October 2004 (22+ years old) and is registered under CIN U24231TZ2004PTC011374.
PRS Pharmaceuticals has 3 current directors:
- Rajamanickam - Managing Director
- Rajendran - Director
- Sekar Raji - Director
The latest financial statements of PRS Pharmaceuticals on record with the MCA are for the year ended 31 March 2021. Its last annual general meeting was held on 30 November 2021. Year-wise statements from 2015 are in the company report.
The GSTIN of PRS Pharmaceuticals is 33AAECP0186F1ZP, registered in Tamil Nadu.
The CIN (Corporate Identification Number) of PRS Pharmaceuticals is U24231TZ2004PTC011374. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
PRS Pharmaceuticals was incorporated on 04 October 2004, making it 22+ years old. It is registered with the Registrar of Companies, Coimbatore.
The peers of PRS Pharmaceuticals by revenue are Kaisha Lifesciences Private Limited, Bileshwar Pharmaceuticals Private Limited, Chereso Life Sciences Private Limited, Delexcel Pharma Private Limited, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Perumal Ramar ceased to be Director on 02 Feb 2021. Mohamedmohideen Hasanmohammed ceased to be Director on 01 Jun 2019. Rajendran ceased to be Additional Director on 30 Sep 2015. PRS Pharmaceuticals has 6 board changes on record in total.
The registered office of PRS Pharmaceuticals is at No. 9 Udayar Thottam Mallamoopampatty, Salem, Tamil Nadu, India – 636302.
PRS Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.
PRS Pharmaceuticals has open charges of ₹77.47 Lakh and no satisfied charges on record as per latest MCA filings.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
